Advancements in nanotechnology have had massive effects on pharmacology, medicine and engineering. In particular, nanomaterials are being largely used in biomedical applications thanks to their ability to interact with organs and tissues at the molecular and cellular levels.

Owing to this peculiar ability, nanomaterials may be used to broadcast active signals to target molecular sensors or cells. However, along with the excitement that has driven the development of novel nanomaterials, there have been increasing concerns regarding the risks this objects may elicit. Therefore, as these nanostructures are intentionally engineered to target specific cells, it is important to ensure that these enhancements do not trigger adverse effects. In this context, this research project aims to create and characterize safe “nanoshuttles” for delivery of drugs through blood brain barrier (BBB).